WallStSmart

IHS Holding Ltd (IHS)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 676% more annual revenue ($12.76B vs $1.65B). WELL leads profitability with a 12.1% profit margin vs 8.6%. IHS trades at a lower P/E of 5.2x. IHS earns a higher WallStSmart Score of 59/100 (C).

IHS

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 5.5Value: 5.7Quality: 6.0
Piotroski: 5/9Altman Z: -0.68

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

IHSSignificantly Overvalued (-75.8%)

Margin of Safety

-75.8%

Fair Value

$4.80

Current Price

$8.42

$3.62 premium

UndervaluedFair: $4.80Overvalued
WELLSignificantly Overvalued (-83.9%)

Margin of Safety

-83.9%

Fair Value

$126.32

Current Price

$228.87

$102.55 premium

UndervaluedFair: $126.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IHS4 strengths · Avg: 9.5/10
P/E RatioValuation
5.2x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
144.8%10/10

Earnings expanding 144.8% YoY

Debt/EquityHealth
-19.2110/10

Conservative balance sheet, low leverage

Operating MarginProfitability
20.5%8/10

Strong operational efficiency at 20.5%

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

IHS2 concerns · Avg: 2.0/10
Return on EquityProfitability
-6380.0%2/10

ROE of -6380.0% — below average capital efficiency

Altman Z-ScoreHealth
-0.682/10

Distress zone — elevated risk

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : IHS

The strongest argument for IHS centers on P/E Ratio, EPS Growth, Debt/Equity. Revenue growth of 10.4% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : IHS

The primary concerns for IHS are Return on Equity, Altman Z-Score.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Key Dynamics to Monitor

IHS profiles as a value stock while WELL is a growth play — different risk/reward profiles.

WELL carries more volatility with a beta of 0.76 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

IHS scores higher overall (59/100 vs 57/100) and 10.4% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

IHS Holding Ltd

REAL ESTATE · REAL ESTATE SERVICES · USA

IHS Holding Limited owns, operates and develops shared telecommunications infrastructure in Africa, Latin America, Europe and the Middle East. The company is headquartered in London, the United Kingdom.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?